Abstract:Background: Buspirone is used for the management of depression and anxiety disorders. Due to its short half-life and low bioavailability, it requires multiple daily doses and is associated with some side effects. background: Buspirone is used for depression and anxiety disorders treatment. Due to its short half-life and low bioavailability, it requires multiple daily doses and is associated with some side effects. Aim: This study aimed to develop chitosan-based hydrogels as drug-controlled release carriers. Objective: The objective of this study is to prepare chitosan-based hydrogels as controlled release carriers in order to overcome the side effects of buspirone HCl and improve patients' compliance and their life quality. Methods: Polymer chitosan was polymerized with two monomers, acrylic acid and itaconic acid, to synthesize pH-sensitive hydrogel. The Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) analysis were performed to confirm the structure formation and thermal stability. Water penetration capability and loading of the drug were performed by porosity and drug loading studies. The swelling and dissolution tests were performed to analyze the pH-sensitive nature of the developed hydrogels. result: The FTIR, XRD, TGA, DSC demonstrated that the chitosan-based hydrogels were successfully prepared. synthesis excellent stability, porosity, swelling, loading, and drug release properties. An increase in water penetration and drug loading into the hydrogel network was seen with the high incorporation of chitosan, AA, and IT, while a drop was seen with a high MBA concentration. In the swelling and dissolution studies, the result revealed that prepared hydrogel offered greatest swelling index and release amount of drug at high pH 7.4. The swelling index and drug release from the designed hydrogel were affected by the concentrations of the incorporated contents. Compared with commercial tablets, the controlled release mode was achieved by using chitosan-based hydrogel as a delivery carrier. Results: FTIR, TGA, and DSC demonstrated that the chitosan-based hydrogels were successfully prepared. An increase in water penetration and drug loading into the hydrogel network was seen with the high incorporation of chitosan, acrylic acid, and itaconic acid. The swelling and dissolution studies revealed that prepared hydrogel offered the greatest swelling and drug release at a high pH of 7.4. The swelling and drug release from the hydrogel were affected by the concentrations of the incorporated contents. A controlled release of the drug was achieved by using chitosan-based hydrogel as a delivery carrier compared to commercial tablets of buspirone. Conclusion: The results showed that the developed chitosan-based hydrogel can be considered one of the most suitable drug carrier systems for the controlled delivery of buspirone.

Preparation and Evaluation of O -Carboxymethyl Chitosan/cyclodextrin Nanoparticles As Hydrophobic Drug Delivery Carriers

Synthesis and Characterization of Fucoidan/chitosan-Coated Nanoliposomes for Enhanced Stability and Oral Bioavailability of Hydrophilic Catechin and Hydrophobic Juglone

Novel Nanoparticles Composed of Chitosan and Β-Cyclodextrin Derivatives As Potential Insoluble Drug Carrier

Preparation and Characterization of Β-Cyclodextrin Grafted N-maleoyl Chitosan Nanoparticles for Drug Delivery

Preparation of Chitosan/Cyclodextrin/Trisodium Citrate Nanoparticles for the Poor-Water Drug Carrier Material

Preparation, Characterization of Hydrophilic and Hydrophobic Drug in Combine Loaded Chitosan/cyclodextrin Nanoparticles and in Vitro Release Study

Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery

Building a polysaccharide hydrogel capsule delivery system for control release of ibuprofen

Chitosan-graft-β-cyclodextrin Nanoparticles As a Carrier for Controlled Drug Release.

Insight into the role of integrated carbohydrate polymers (starch, chitosan, and β-cyclodextrin) with mesoporous silica as carriers for ibuprofen drug; equilibrium and pharmacokinetic properties

Preparation, optimisation, and properties of O-carboxymethyl chitosan-g-cholesterol succinic acid monoester polymer nanomicelles

Preparation of carboxymethylcellulose / ZnO / chitosan composite hydrogel microbeads and its drug release behaviour

Preparation, Swelling, and Drug Release Studies of Chitosan-based Hydrogels for Controlled Delivery of Buspirone Hydrochloride

Ionic Gelated Β-Cyclodextrin-biotin-carboxymethyl Chitosan Nanoparticles Prepared As Carrier for Oral Delivery of Protein Drugs

Preparation and Evaluation of Chitosan/β‐cyclodextrin Magnetic Nanoparticles As a Photodegradable and Hydrophobic Drug Delivery Carrier

Synthesis of Chitosan/Diatomite Composite as an Advanced Delivery System for Ibuprofen Drug; Equilibrium Studies and the Release Profile

Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index

In Vitro Evaluation of Mucoadhesion and Permeation Enhancement of Polymeric Amphiphilic Nanoparticles.

Chitosan/sodium Tripolyphosphate Nanoparticles: Preparation, Characterization and Application As Drug Carrier.

Study of Hydroxypropyl β-Cyclodextrin and Puerarin Inclusion Complexes Encapsulated in Sodium Alginate-Grafted 2-Acrylamido-2-Methyl-1-Propane Sulfonic Acid Hydrogels for Oral Controlled Drug Delivery

Preparation, Characterization And In Vitro Release Study Of Drug-Loaded Sodium Carboxy-Methylcellulose/Chitosan Composite Sponge